Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 4/20 | 0.36 |
| ▸ | CA2 | P00918 | 4/20 | 0.36 |
| ▸ | CA12 | O43570 | 3/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.35 |
| ▸ | CA9 | Q16790 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.35 |
| ▸ | CA5A | P35218 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6191884 | 0.83 | ALDH1A1 (0.47) | ALDH1A1ADRA2BPTGS1TDP1CA1 | |
| SCHEMBL12520412 | 0.78 | CYP1A2 (0.49) | ALDH1A1ADRA2BPTGS1TDP1KDM4E | |
| SCHEMBL7693285 | 0.77 | APP (0.43) | ALDH1A1PTGS1CA2KDM4EMEN1 | |
| SCHEMBL4940219 | 0.77 | CD44 (0.37) | ALDH1A1TDP1CA1CA2CA12 | |
| SCHEMBL27484653 | 0.77 | S1PR1 (0.38) | ALDH1A1MCL1ELANECTSG | |
| SCHEMBL9646614 | 0.76 | ALDH1A1 (0.50) | ALDH1A1ADRA2BPTGS1TDP1CA1 | |
| SCHEMBL1257433 | 0.76 | ALDH1A1 (0.36) | ALDH1A1TDP1CA1CA2CA12 | |
| SCHEMBL10962501 | 0.75 | SLC22A12 (0.35) | ALDH1A1TDP1MEN1LMNAMAPT | |
| SCHEMBL5655874 | 0.75 | CA12 (0.53) | CA1CA2CA12CA14KDM4E | |
| SCHEMBL5587038 | 0.74 | HTR4 (0.36) | ALDH1A1KDM4EMEN1MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109799127-A | Dilute the analysis method of biological specimen ingredient | 立佳有限公司 | 2019-05-24 | — | — | CN | disclosed |
| CN-109799126-A | Dilute the analysis method of biological specimen ingredient | 立佳有限公司 | 2019-05-24 | — | — | CN | disclosed |
| CN-109477837-A | Method, composition and chip for detecting analyte in blood sample | 泰尔茂株式会社 | 2019-03-15 | — | — | CN | disclosed |
| CN-107076728-A | Analytical method for diluting biological sample components | 立佳有限公司 | 2017-08-18 | — | — | CN | disclosed |
| US-20040247629-A1 | Anhydrous cosmetic makeup composition containing a fatty phase and a cosmetic treatment process using the composition | L'OREAL | 2004-12-09 | — | — | US | disclosed |
| US-6572870-B2 | Mixture containing oils, lipids and surfactants | L'OREAL (FR) | 2003-06-03 | — | — | US | disclosed |
| US-20010055601-A1 | Anhydrous cosmetic makeup composition containing a fatty phase and a cosmetic treatment process using the composition | L'OREAL | 2001-12-27 | — | — | US | disclosed |
| US-6319508-B1 | ANHYDROUS COSMETIC MAKEUP COMPOSITION FOR APPLICATION TO SKIN OR LIPS CONSISTING ESSENTIALLY OF MIXTURE OF FATTY PHASE AND PROVESICULAR LIPID PHASE ALSO CONTAINING AT LEAST ONE COSMETIC AND/OR DERMOPHARMACEUTICAL ACTIVE MATERIAL | L'OREAL (FR) | 2001-11-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010055601-A1 | Anhydrous cosmetic makeup composition containing a fatty phase and a cosmetic treatment process using the composition | FABP4, CUTA, LIPA | ALDH1A1 948/4885ADRA2B 1824/4885PTGS1 2804/4885 |
| US-20040247629-A1 | Anhydrous cosmetic makeup composition containing a fatty phase and a cosmetic treatment process using the composition | FABP4, CUTA, LIPA | ALDH1A1 948/4885ADRA2B 1824/4885PTGS1 2804/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.